Pharmacokinetics and brain uptake study of novel AMPA receptor antagonist perampanel in SD rats using a validated UHPLC-QTOF-MS method

Paul, D; Allakonda, L; Sahu, A; Surendran, S; Satheeshkumar, N

Satheeshkumar, N (reprint author), NIPER, Dept Pharmaceut Anal, Drug Metab & Interact Res Lab, Hyderabad 500037, Telangana, India.

JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2018; 149 (): 234

Abstract

Perampanel (PER) is a novel AMPA receptor antagonist for antiepileptic therapy and is prospective for the treatment of other neurological disorders. A......

Full Text Link